These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19124968)

  • 1. [Indications for platelet transfusion].
    Adukauskiene D; Kinderyte A; Veikutiene A
    Medicina (Kaunas); 2008; 44(11):905-9. PubMed ID: 19124968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Transfusion Practices in Critically Ill Children.
    Nellis ME; Karam O; Mauer E; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
    Crit Care Med; 2018 Aug; 46(8):1309-1317. PubMed ID: 29727368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study.
    Warner MA; Chandran A; Frank RD; Kor DJ
    Anesth Analg; 2019 Feb; 128(2):288-295. PubMed ID: 29293185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications and contraindications for platelet transfusions in patients with thrombocytopenia].
    Tomicić M; Vuk T; Hundrić-Haspl Z
    Lijec Vjesn; 2014; 136(3-4):90-3. PubMed ID: 24988744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic use of platelets in critically ill patients with thrombocytopaenia: A retrospective two-centre observational study.
    O'Bryan LJ; Bedford J; Redfern OC; Hatch RA; Young JD; Watkinson PJ
    J Crit Care; 2020 Jun; 57():157-167. PubMed ID: 32163751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
    Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
    Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transfusion platelet responses in critically ill cancer patients with hypoproliferative thrombocytopenia.
    Baron E; Charpentier J; François A; Ben Hadj Amor H; Habr B; Cariou A; Chiche JD; Mira JP; Jamme M; Pène F
    Transfusion; 2020 Feb; 60(2):275-284. PubMed ID: 31724828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The practice of platelet transfusion in the intensive care unit.
    Salman SS; Fernández Pérez ER; Stubbs JR; Gajic O
    J Intensive Care Med; 2007; 22(2):105-10. PubMed ID: 17469241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.
    van de Weerdt EK; Biemond BJ; Zeerleder SS; van Lienden KP; Binnekade JM; Vlaar APJ;
    Trials; 2018 Feb; 19(1):127. PubMed ID: 29463280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
    Benjamin RJ; Anderson KC
    Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet therapy.
    Choudhry VP
    Indian J Pediatr; 2002 Sep; 69(9):779-83. PubMed ID: 12420911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical perspectives of platelet transfusions: defining the optimal dose.
    Strauss RG
    J Clin Apher; 1995; 10(3):124-7. PubMed ID: 8582893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.